Computed tomography perfusion imaging of renal cell carcinoma: Systematic comparison with histopathological angiogenic and prognostic markers

Investigative Radiology

Volumn 48, Issue 4, 2013, Pages 183-191

  Reiner, Caecilia S ^a,b   Roessle, Matthias ^c   Thiesler, Thore ^c   Eberli, Daniel ^c   Klotz, Ernst ^d   Frauenfelder, Thomas ^a   Sulser, Tullio ^c   Moch, Holger ^c   Alkadhi, Hatem ^a  

^a University Hospital Zurich Institut fur Diagnostische Radiologie   (Switzerland)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d SIEMENS AG   (Germany)

Author keywords

Angiogenesis; Computed tomography; Microvessel density; Perfusion imaging; Renal cell carcinoma; Tumor necrosis

Indexed keywords

IOPROMIDE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED SCINTIGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PERFUSION; LYMPH VESSEL; MALE; MICROVASCULATURE; PRIORITY JOURNAL; STAINING; TUMOR NECROSIS;

EID: 84874938372     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31827c63a3     Document Type: Article

References (47)

1. Dekel Y, Koren R, Kugel V, et al. Significance of angiogenesis and microvascular invasion in renal cell carcinoma. Pathol Oncol Res. 2002;8:129-132. (Pubitemid 34988063)
2. Sabo E, Boltenko A, Sova Y, et al. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res. 2001;7:533-537. (Pubitemid 32707975)
3. Schraml P, Struckmann K, Hatz F, et al. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol. 2002;196:186-193. (Pubitemid 34110900)
4. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renalcell carcinoma. N Engl J Med. 2007;356:125-134. (Pubitemid 46089673)
5. Escudier B, Eisen T, Stadler WM, et al. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol. 2009;27:3312-3318.
6. Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol. 2009;27:3584-3590.
7. Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am. 2009;47:161-178.
8. Bhatt RS, Seth P, Sukhatme VP. Biomarkers for monitoring antiangiogenic therapy. Clin Cancer Res. 2007;13:777s-780s.
9. Yildiz E, Ayan S, Goze F, et al. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int. 2008;101:758-764. (Pubitemid 351270001)
10. de Peralta-Venturina M, Moch H, Amin M, et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001;25:275-284. (Pubitemid 32174196)
11. Moch H, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604-614. (Pubitemid 30640107)
12. Baldewijns MM, Thijssen VL, Van den Eynden GG, et al. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Br J Cancer. 2007;96:1888-1895. (Pubitemid 46912016)
13. Delahunt B, Bethwaite PB, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol. 1997;80:401-404. (Pubitemid 28312844)
14. Fox SB, Harris AL. Histological quantitation of tumour angiogenesis. APMIS. 2004;112:413-430. (Pubitemid 39626050)
15. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006;54:385-395.
16. Padhani AR, Miles KA. Multiparametric imaging of tumor response to therapy. Radiology. 2010;256:348-364.
17. Goh V, Ng QS, Miles K. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? Invest Radiol. 2012;47:2-4.
18. Goetti R, Reiner CS, Knuth A, et al. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Invest Radiol. 2012;47:18-24.
19. Goetti R, Leschka S, Desbiolles L, et al. Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases. Invest Radiol. 2010;45:419-426.
20. Helck A, Sommer WH, Klotz E, et al. Determination of glomerular filtration rate using dynamic CT-angiography: simultaneous acquisition of morphological and functional information. Invest Radiol. 2010;45:387-392.
21. Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol. 1991;64:409-412.
22. Sobin LH, Gospodarowicz MK, Wittekind C, et al. TNM Classification of Malignant Tumours. 7th ed. Chichester,West Sussex,UK:Wiley-Blackwell; 2010.
23. Beresford MJ, Harris AL, Ah-See M, et al. The relationship of the neoangiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. Br J Cancer. 2006;95:1683-1688. (Pubitemid 44950794)
24. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasisV correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
25. Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr. 2000;24:835-842. (Pubitemid 32201804)
26. Cyran CC, von Einem JC, Paprottka PM, et al. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas. Invest Radiol. 2012;47:49-57.
27. Jiang T, Kambadakone A, Kulkarni NM, et al. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol. 2012;47:11-17.
28. Ren Y, Fleischmann D, Foygel K, et al. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice. Invest Radiol. 2012;47:25-32.
29. Fournier LS, Oudard S, Thiam R, et al. Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology. 2010;256:511-518.
30. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-198. (Pubitemid 32148486)
31. Chen TW, Yang ZG, Wang QL, et al. Whole tumour quantitative measurement of first-pass perfusion of oesophageal squamous cell carcinoma using 64-row multidetector computed tomography: correlation with microvessel density. Eur J Radiol. 2011;79:218-223.
32. Ash L, Teknos TN, Gandhi D, et al. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology. 2009;251:422-428.
33. Feng ST, Sun CH, Li ZP, et al. Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging. Eur J Radiol. 2010;75:191-196.
34. Chen Y, Zhang J, Dai J, et al. Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging. 2010;35:622-628.
35. Reiner CS, Goetti R, Eberli D, et al. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis. Invest Radiol. 2012;47:33-40.
36. Goh V, Halligan S, Daley F, et al. Colorectal tumor vascularity: quantitative assessment with multidetector CTVdo tumor perfusion measurements reflect angiogenesis? Radiology. 2008;249:510-517.
37. Tacelli N, Remy-Jardin M, Copin MC, et al. Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients. Radiology. 2010; 257:863-871.
38. d'Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009;250:407-416.
39. Wang JH, Min PQ, Wang PJ, et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol. 2006;186:1423-1430.
40. Li Y, Yang ZG, Chen TW, et al. Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer. 2008;61:44-53. (Pubitemid 351862323)
41. Bali MA,Metens T, Denolin V, et al. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters. Radiology. 2011;261:456-466.
42. Atkin G, Taylor NJ, Daley FM, et al. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis. Br J Surg. 2006;93:992-1000. (Pubitemid 44214851)
43. Voss M, Steidler A, Grobholz R, et al. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma. BJU Int. 2009;104:94-99.
44. Iwata T, Miyata Y, Kanda S, et al. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry. Urology. 2008;71:749-754.
45. Mertz KD, Demichelis F, Kim R, et al. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. Hum Pathol. 2007;38:1454-1462. (Pubitemid 47418973)
46. Kohler HH, Barth PJ, Siebel A, et al. Quantitative assessment of vascular surface density in renal cell carcinomas. Br J Urol. 1996;77:650-654. (Pubitemid 27402269)
47. Edeline J, Mottier S, Vigneau C, et al. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma. Hum Pathol. 2012;43:1982-1990.